Neugebauer; Witold
Patent Applications and Registrations
Patent applications and USPTO patent grants for Neugebauer; Witold.The latest application filed is for "peptidic and peptidoid bradykinin b1 receptor antagonists and uses thereof".
- Neugebauer; Witold - Ottawa CA
| Patent | Date |
|---|---|
| Peptidic And Peptidoid Bradykinin B1 Receptor Antagonists And Uses Thereof App 20080064642 - Guerin; Brigitte ; et al. | 2008-03-13 |
| Selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof Grant 7,211,566 - Regoli , et al. May 1, 2 | 2007-05-01 |
| Parathyroid hormone analogues for the treatment of osteoporosis Grant 6,541,450 - Barbier , et al. April 1, 2 | 2003-04-01 |
| Parathyroid hormone analogues for the treatment of osteoporosis Grant 6,110,892 - Barbier , et al. August 29, 2 | 2000-08-29 |
| Parathyroid hormone analogues for the treatment of osteoporosis Grant 5,955,425 - Morley , et al. September 21, 1 | 1999-09-21 |
| Parathyroid hormone analogues for the treatment of osteoporosis Grant 5,556,940 - Willick , et al. September 17, 1 | 1996-09-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 